global provider of customized laboratory and research services

MSS now offers the Illumina verifi® prenatal test in Canada

Agreement Establishes Expanded Canadian Availability of verifi®

Mount Sinai Services Inc. (Mount Sinai) a global provider of customized laboratory and research services, today announced a distribution agreement with Illumina, Inc. to provide the verifi® prenatal test(1) to pregnant women in Ontario who are at risk of having a fetus with a chromosomal abnormality. Mount Sinai will also have flexibility to provide the test in other Canadian regions.

“We are extremely pleased to partner with Illumina in Ontario, to bring pregnant women unprecedented access to what we believe is the superior non-invasive prenatal test to detect chromosomal abnormalities,” said Azar Azad, Managing Director of Mount Sinai Services. “The verifi® prenatal test exemplifies Mount Sinai’s clinical and research leadership in women’s health and our commitment to offer clinically-validated, innovative new solutions to Ontario women to improve their health and quality of life. We strongly believe that the verifi® prenatal test will have an ongoing positive impact for women and their families in Ontario.”

“As we expand our global presence in reproductive and genetic health, we are pleased to partner with Mount Sinai in Ontario, a clear leader in customized laboratory services throughout Canada,” said Vance Vanier, M.D., Vice President of Marketing for Illumina’s Reproductive and Genetic Health business.

“Illumina is at the forefront of improving non-invasive prenatal testing options to provide the highest detection capability for the most common chromosomal abnormalities, and through this agreement, more pregnant women will receive accurate and reliable results simply, from a single blood draw.”

About Mount Sinai Services, Inc. (Mount Sinai)

MOUNT SINAI SERVICES is a global provider of customized laboratory and research services. We work closely with Mount Sinai Hospital’s state-of-the-art laboratories and world-renowned clinicians and researchers to offer comprehensive services supporting discovery and innovation in the life sciences, including analytical testing, medical device and diagnostic assay development and validation, and clinical trial management services.

Mount Sinai is committed to providing our clients with superior customer service and high-quality results based on a truly collaborative approach. For information, visit www.mountsinaiservices.com.

(1) The verifi® prenatal test is a non-invasive blood test that analyzes DNA found in a pregnant woman’s blood to detect the most common fetal chromosome abnormalities, including Down syndrome (trisomy 21 or T21), Edwards syndrome (trisomy 18 or T18), Patau syndrome (trisomy 13 or T13) and sex chromosome abnormalities.